Olmesartán Teva (Olmesartan Medoxomil)

Olmesartan medoxyl, the active ingredient in Olmesartán Teva, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension and helps protect kidneys in patients with type 2 diabetes.

GNH USA supplies Olmesartán Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxyl is used to manage conditions that involve the renin‑angiotensin system. - Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Diabetic nephropathy: slows progression of kidney damage in type 2 diabetes. - Heart failure prevention: assists in preventing heart‑failure related events in high‑risk patients.

Olmesartan medoxyl may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Upper respiratory tract infection

Serious or Rare Side Effects: - Angio‑ema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevation - Bullous skin reactions

When prescribing Olmesartan medoxyl, clinicians should consider several safety aspects. - Monitor blood pressure: ensure adequate control without excessive lowering. - Assess renal function: check creatinine and electrolytes before initiation and periodically. - Review potassium levels: hyper‑kalaemia risk requires monitoring, especially with potassium‑sparing diuretics. - Avoid in pregnancy: drug is contraindicated during the first trimester. - Caution in elderly: start with lower dose and monitor for orthostatic symptoms. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Olmesartan medoxyl can interact with several medicines that affect blood pressure, electrolytes, or renal function.

Major Interactions (Avoid): - Aliskiren combined with oligo‑conception? (…)